FAM88C: A Potential Drug Target and Biomarker for Family with Sequence Similarity 88

Target Name: FAM88C

NCBI ID: G102724238

FAM88C

Other Name(s): family with sequence similarity 88 member C | Lnc-PPRL | Family with sequence similarity 88 member C

FAM88C: A Potential Drug Target and Biomarker for Family with Sequence Similarity 88

FAM88C is a gene located on chromosome 16 that has been identified as a potential drug target and biomarker for families with sequence similarity 88 (FS88).FS88 families are a group of genetic disorders characterized by the presence of a specific missense mutation that results in the substitution of a thymine base (T) for a guanine base (G) at position 88 of a gene. This mutation can lead to the production of an abnormally processed protein that can cause a range of cellular and physiological problems, including developmental delays, intellectual disabilities, and chronic diseases.

The discovery of FAM88C as a potential drug target and biomarker for FS88 families has significant implications for the treatment of this genetic disorder. While there are currently no FDA-approved drugs that can specifically target FAM88C, research into this gene has the potential to lead to the development of new treatments for FS88 families.

Understanding FAM88C and its Function

FAM88C is a member of the KH domain, which is a family of proteins that are characterized by a specific arrangement of amino acids. The KH domain is known for its ability to interact with various molecules, including DNA and RNA, and is involved in the regulation of gene expression.

The FAM88C gene has been identified as a gene that is affected by the substitution of a thymine base (T) for a guanine base (G) at position 88. This mutation has been shown to result in the production of an abnormally processed protein that is not fully synthesized. This protein is thought to play a role in the regulation of cellular processes, including cell signaling and DNA replication.

While the exact function of FAM88C is not yet fully understood, research has shown that it is involved in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The Potential for Drug Targeting

FAM88C has been identified as a potential drug target for FS88 families due to its involvement in the regulation of cellular processes and its association with a range of diseases. While drug targeting for FAM88C is still in its early stages, research into this gene has the potential to lead to the development of new treatments for FS88 families.

One approach to drug targeting for FAM88C is to target the KH domain itself, which is known for its ability to interact with various molecules. This can involve the development of small molecules or antibodies that specifically bind to FAM88C and prevent it from interacting with its target molecules.

Another approach to drug targeting for FAM88C is to target the abnormally processed protein that is produced by the FAM88C mutation. This can involve the development of drugs that specifically target the protein and prevent it from being synthesized.

The Potential for Biomarkers

While drug targeting for FAM88C is still in its early stages, research into this gene has the potential to lead to the development of new biomarkers for FS88 families. One approach to developing biomarkers for FAM88C is to use techniques such as genetic linkage and association studies to identify genetic markers that are associated with the development of FS88 families.

Another approach to developing biomarkers for FAM88C is to use techniques such as protein expression and knockdown to reduce the amount of abnormally processed protein produced by the FAM88C mutation. This can result in the production of a stable protein that can be used as a biomarker for FS88 families.

Conclusion

FAM88C is a gene that has significant potential as a drug target and biomarker for families with sequence similarity 88. While the exact function of FAM88C is not yet fully understood, research into this gene has the potential to lead to the development of new treatments for FS88 families. Further research is needed to fully understand the role of FAM88C in the development and progression of diseases and to develop effective biomarkers for this genetic disorder.

Protein Name: Family With Sequence Similarity 88 Member C

The "FAM88C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM88C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets